The Trump administration eliminated the CDC team that developed national guidelines for prescribing contraception safely for ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...

The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence ...

Weeks after President Donald Trump took office, multiple government webpages referencing gender and sexual orientation ...

Furthermore, the most recent U.S. Preventive Services Task Force (USPSTF) guidelines have endorsed previous CDC recommendations for screening only in areas where HIV prevalence is 1% or higher ...

In two recent studies, this new shot reportedly nearly eliminated new infections in people at substantial risk of HIV.

The agenda for managing HIV care is still in constant evolution and will continue to evolve until HIV can be either prevented by vaccine or eradicated from infected people, or both.

Health and Human Services Secretary Robert F. Kennedy Jr. testified in front of the House Committee on Energy and Commerce ...

Merck announced ACIP voted to recommend Enflosnia (clesrovimab-cfor) as a treatment option for RSV in infants younger than 8 months of age who are born during or entering their first RSV season.